Absence of hereditary p53 mutations in 10 familial leukemia pedigrees. 1992

C A Felix, and D D'Amico, and T Mitsudomi, and M M Nau, and F P Li, and J F Fraumeni, and D E Cole, and J McCalla, and G H Reaman, and J Whang-Peng
Pediatric Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Germline p53 mutations have been identified in the Li-Fraumeni syndrome but the role of such mutations in familial leukemia is not established. The p53 gene was examined by single-strand conformation polymorphism analysis of exons 4-8 in 10 families with multiple members affected with leukemia. The diagnoses included acute and chronic leukemias and Hodgkin's disease. Identified in two families were p53 mutations that were nonhereditary. These included a 2-bp deletion in exon 6 found in the lymphoblast DNA of one child whose sibling, cousin, and several adult relatives had acute leukemia. The other nonhereditary p53 mutation was a transition at codon 248 (CGG to CAG, arginine to glutamine) found in the lymphoblasts of a patient with a preleukemic syndrome and acute lymphoblastic leukemia (ALL) whose brother is a long-term survivor of ALL. Thus, p53 mutations were found to occur in two families but both were nonhereditary. Moreover, in the remaining eight families no p53 mutation was identified in the regions of p53 where most mutations have been found in other cancers. Although p53 mutations sometimes may be present, they do not appear to be a primary event responsible for hereditary susceptibility to familial leukemia. This study suggests involvement of other genes or mechanisms.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015183 Restriction Mapping Use of restriction endonucleases to analyze and generate a physical map of genomes, genes, or other segments of DNA. Endonuclease Mapping, Restriction,Enzyme Mapping, Restriction,Site Mapping, Restriction,Analysis, Restriction Enzyme,Enzyme Analysis, Restriction,Restriction Enzyme Analysis,Analyses, Restriction Enzyme,Endonuclease Mappings, Restriction,Enzyme Analyses, Restriction,Enzyme Mappings, Restriction,Mapping, Restriction,Mapping, Restriction Endonuclease,Mapping, Restriction Enzyme,Mapping, Restriction Site,Mappings, Restriction,Mappings, Restriction Endonuclease,Mappings, Restriction Enzyme,Mappings, Restriction Site,Restriction Endonuclease Mapping,Restriction Endonuclease Mappings,Restriction Enzyme Analyses,Restriction Enzyme Mapping,Restriction Enzyme Mappings,Restriction Mappings,Restriction Site Mapping,Restriction Site Mappings,Site Mappings, Restriction
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D016158 Genes, p53 Tumor suppressor genes located on the short arm of human chromosome 17 and coding for the phosphoprotein p53. Genes, TP53,TP53 Genes,p53 Genes,Gene, TP53,Gene, p53,TP53 Gene,p53 Gene

Related Publications

C A Felix, and D D'Amico, and T Mitsudomi, and M M Nau, and F P Li, and J F Fraumeni, and D E Cole, and J McCalla, and G H Reaman, and J Whang-Peng
November 1995, Leukemia,
C A Felix, and D D'Amico, and T Mitsudomi, and M M Nau, and F P Li, and J F Fraumeni, and D E Cole, and J McCalla, and G H Reaman, and J Whang-Peng
February 1996, Oncogene,
C A Felix, and D D'Amico, and T Mitsudomi, and M M Nau, and F P Li, and J F Fraumeni, and D E Cole, and J McCalla, and G H Reaman, and J Whang-Peng
November 1999, American journal of hematology,
C A Felix, and D D'Amico, and T Mitsudomi, and M M Nau, and F P Li, and J F Fraumeni, and D E Cole, and J McCalla, and G H Reaman, and J Whang-Peng
February 1992, The Journal of clinical investigation,
C A Felix, and D D'Amico, and T Mitsudomi, and M M Nau, and F P Li, and J F Fraumeni, and D E Cole, and J McCalla, and G H Reaman, and J Whang-Peng
July 1993, Leukemia,
C A Felix, and D D'Amico, and T Mitsudomi, and M M Nau, and F P Li, and J F Fraumeni, and D E Cole, and J McCalla, and G H Reaman, and J Whang-Peng
January 2016, Human genome variation,
C A Felix, and D D'Amico, and T Mitsudomi, and M M Nau, and F P Li, and J F Fraumeni, and D E Cole, and J McCalla, and G H Reaman, and J Whang-Peng
October 2018, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology,
C A Felix, and D D'Amico, and T Mitsudomi, and M M Nau, and F P Li, and J F Fraumeni, and D E Cole, and J McCalla, and G H Reaman, and J Whang-Peng
July 2004, Bone,
C A Felix, and D D'Amico, and T Mitsudomi, and M M Nau, and F P Li, and J F Fraumeni, and D E Cole, and J McCalla, and G H Reaman, and J Whang-Peng
January 1997, American journal of respiratory cell and molecular biology,
C A Felix, and D D'Amico, and T Mitsudomi, and M M Nau, and F P Li, and J F Fraumeni, and D E Cole, and J McCalla, and G H Reaman, and J Whang-Peng
January 2012, Journal of pediatric endocrinology & metabolism : JPEM,
Copied contents to your clipboard!